12:00 AM
 | 
Nov 08, 1999
 |  BC Week In Review  |  Clinical News  |  Clinical Status

AG7088: Began Phase II trial

Agouron Pharmaceuticals Inc., La Jolla, Calif.
Product: AG7088
Business: Infectious diseases
Therapeutic category: Viral replication
Target:...

Read the full 56 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >